Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.898
Sell
RSI(14)
50.874
Neutral
STOCH(KDJ)(9,3,3)
61.772
Buy
ATR(14)
2.685
Low Volatility
CCI(14)
-7.750
Neutral
Williams %R
62.674
Sell
TRIX(12,20)
-0.054
Sell
StochRSI(14)
100.000
Overbought
Quest Diagnostics Inc
DGX182.560USD
0.000
Close 12/15, 16:00（ET）Quotes delayed by 15 min
20.26BMarket Cap
21.19P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Quest Diagnostics Inc
Currency: USD Updated: 2025-12-12Key Insights
Quest Diagnostics Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 15/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 196.72.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Quest Diagnostics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
20
analysts
Buy
Current Rating
196.716
Target Price
+8.19%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Quest Diagnostics Inc Highlights
StrengthsRisks
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 38.22%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 38.22%.
Overvalued
The company’s latest PE is 21.19, at a high 3-year percentile range.
Held by Private Capital
Star Investor Private Capital holds 8.70K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-12The current financial score of Quest Diagnostics Inc is 9.06, ranking 6/78 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 2.82B, representing a year-over-year increase of 13.18%, while its net profit experienced a year-over-year increase of 8.00%.
Score
Financials
6.47
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
9.50
Operational Efficiency
9.66
Growth Potential
10.00
Shareholder Returns
9.68
Quest Diagnostics Inc's Company Valuation
Currency: USD Updated: 2025-12-12The current valuation score of Quest Diagnostics Inc is 6.63, ranking 53/78 in the Healthcare Providers & Services industry. Its current P/E ratio is 21.19, which is 7.04% below the recent high of 22.68 and 23.56% above the recent low of 16.20.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 15/78
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-12The current earnings forecast score of Quest Diagnostics Inc is 7.40, ranking 40/78 in the Healthcare Providers & Services industry. The average price target for Quest Diagnostics Inc is 198.00, with a high of 215.00 and a low of 169.18.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
20
analysts
Buy
Current Rating
196.716
Target Price
+8.19%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
65
Total
7
Median
9
Average
Company name
Ratings
Analysts
Quest Diagnostics Inc
DGX
20
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
22
1
2
3
...
13
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-12The current price momentum score of Quest Diagnostics Inc is 6.96, ranking 51/78 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 191.34 and the support level at 176.19, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
181.474
Buy
MA10
182.104
Buy
MA20
185.147
Sell
MA50
183.477
Sell
MA100
181.573
Buy
MA200
177.051
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-12The current institutional shareholding score of Quest Diagnostics Inc is 10.00, ranking 1/78 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 99.89%, representing a quarter-over-quarter decrease of 0.33%. The largest institutional shareholder is The Vanguard, holding a total of 14.20M shares, representing 12.77% of shares outstanding, with 2.61% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Boston Partners
JP Morgan Asset Management
Geode Capital Management, L.L.C.
Victory Capital Management Inc.
Dimensional Fund Advisors, L.P.
Wells Fargo Advisors
1
2
Risk Assessment
Currency: USD Updated: 2025-12-12The current risk assessment score of Quest Diagnostics Inc is 9.68, ranking 1/78 in the Healthcare Providers & Services industry. The company's beta value is 0.63. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.64
VaR
+1.96%
240-Day Maximum Drawdown
+9.69%
240-Day Volatility
+24.65%
Return
Best Daily Return
60 days
+2.68%
120 days
+7.08%
5 years
+7.08%
Worst Daily Return
60 days
-4.47%
120 days
-4.47%
5 years
-6.80%
Sharpe Ratio
60 days
+0.19
120 days
+0.33
5 years
+0.62
Risk Assessment
Maximum Drawdown
240 days
+9.69%
3 years
+18.85%
5 years
+30.28%
Return-to-Drawdown Ratio
240 days
+2.26
3 years
+0.42
5 years
+0.35
Skewness
240 days
+0.65
3 years
+0.47
5 years
+0.16
Volatility
Realised Volatility
240 days
+24.65%
5 years
+23.05%
Standardised True Range
240 days
+1.98%
5 years
+1.61%
Downside Risk-Adjusted Return
120 days
+49.88%
240 days
+49.88%
Maximum Daily Upside Volatility
60 days
+15.19%
Maximum Daily Downside Volatility
60 days
+17.25%
Liquidity
Average Turnover Rate
60 days
+0.91%
120 days
+1.05%
5 years
--
Turnover Deviation
20 days
-17.80%
60 days
+1.75%
120 days
+17.93%
Peer Comparison
Healthcare Providers & Services
Quest Diagnostics Inc
DGX
8.10 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Alignment Healthcare Inc
ALHC
8.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
NTRA
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lifestance Health Group Inc
LFST
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
CI
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Option Care Health Inc
OPCH
8.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Quest Diagnostics Inc?
The TradingKey Stock Score provides a comprehensive assessment of Quest Diagnostics Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Quest Diagnostics Inc’s performance and outlook.
How do we generate the financial health score of Quest Diagnostics Inc?
To generate the financial health score of Quest Diagnostics Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Quest Diagnostics Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Quest Diagnostics Inc.
How do we generate the company valuation score of Quest Diagnostics Inc?
To generate the company valuation score of Quest Diagnostics Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Quest Diagnostics Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Quest Diagnostics Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Quest Diagnostics Inc.
How do we generate the earnings forecast score of Quest Diagnostics Inc?
To calculate the earnings forecast score of Quest Diagnostics Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Quest Diagnostics Inc’s future.
How do we generate the price momentum score of Quest Diagnostics Inc?
When generating the price momentum score for Quest Diagnostics Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Quest Diagnostics Inc’s prices. A higher score indicates a more stable short-term price trend for Quest Diagnostics Inc.
How do we generate the institutional confidence score of Quest Diagnostics Inc?
To generate the institutional confidence score of Quest Diagnostics Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Quest Diagnostics Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Quest Diagnostics Inc.
How do we generate the risk management score of Quest Diagnostics Inc?
To assess the risk management score of Quest Diagnostics Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Quest Diagnostics Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Quest Diagnostics Inc.
